Postpolio Syndrome
13
2
3
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
1 terminated out of 13 trials
88.9%
+2.4% vs benchmark
15%
2 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Effectiveness of Transcranial Magnetic Stimulation Treatment in Patients Diagnosed With Postpolio Syndrome
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
Nomad P-KAFO Study
Spinal Cord Gray Matter Imaging in Post Polio Syndrome
Whole Body Vibration on Muscle Strength in Patients With Postpolio Syndrome
L-Citrulline in Patients With Post-Polio Syndrome
Enhance Wellness for Individuals With Long-Term Physical Disabilities
Activity and Fatigue of the Respiratory Muscles and Pulmonary Characteristics in Post-Polio Patients
Glutathione and Health With Post-Polio Syndrome
Intravenous Immunoglobulins for Post-Polio Syndrome
Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)